Cimpress (NASDAQ:CMPR - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "buy" rating to a "hold" rating in a report issued on Sunday.
CMPR has been the topic of a number of other reports. Barrington Research upped their target price on shares of Cimpress from $65.00 to $70.00 and gave the company an "outperform" rating in a report on Monday, August 4th. Truist Financial set a $74.00 price objective on shares of Cimpress and gave the stock a "buy" rating in a report on Wednesday, July 30th.
Get Our Latest Analysis on CMPR
Cimpress Trading Down 0.2%
Shares of NASDAQ CMPR opened at $55.36 on Friday. The stock has a market cap of $1.38 billion, a price-to-earnings ratio of 108.55 and a beta of 1.70. Cimpress has a 52 week low of $35.21 and a 52 week high of $102.22. The company's 50-day moving average price is $47.59 and its 200 day moving average price is $47.58.
Cimpress (NASDAQ:CMPR - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The business services provider reported ($1.02) EPS for the quarter, missing analysts' consensus estimates of $0.97 by ($1.99). The business had revenue of $869.48 million during the quarter, compared to analyst estimates of $844.24 million. Cimpress had a net margin of 0.44% and a negative return on equity of 2.67%. As a group, research analysts expect that Cimpress will post 3.69 earnings per share for the current year.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of the stock. Signaturefd LLC raised its holdings in Cimpress by 341.6% in the first quarter. Signaturefd LLC now owns 605 shares of the business services provider's stock valued at $27,000 after buying an additional 468 shares during the period. Summit Securities Group LLC purchased a new position in Cimpress in the first quarter valued at approximately $32,000. Headlands Technologies LLC purchased a new position in Cimpress in the first quarter valued at approximately $34,000. Ethic Inc. purchased a new position in Cimpress in the fourth quarter valued at approximately $214,000. Finally, Cerity Partners LLC purchased a new position in Cimpress in the first quarter valued at approximately $214,000. 77.64% of the stock is currently owned by hedge funds and other institutional investors.
About Cimpress
(
Get Free Report)
Cimpress plc provides various mass customization of printing and related products in North America, Europe, and internationally. The company operates through five segments: Vista, PrintBrothers, The Print Group, National Pen, and All Other Businesses. It offers printed and digital marketing products; internet-based canvas-print wall décor, business signage, and other printed products; business cards; and marketing materials, such as flyers and postcards, digital and marketing services, writing instruments, decorated apparel, promotional products and gifts, packaging, design services, textiles, and magazines and catalogs.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cimpress, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cimpress wasn't on the list.
While Cimpress currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.